SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
寂漉
Lv3
270 积分
2024-07-20 加入
最近求助
最近应助
互助留言
Identification of novel immuno-oncology compounds as VISTA-Inhibitors for cancer therapy: A computational approach integrating virtual screening and molecular dynamics simulation
14小时前
已完结
76P Highly potent fully human anti-VISTA antibodies efficiently abrogate the interaction of this new target checkpoint inhibitor to its different putative receptors at different pH
14小时前
已关闭
Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy
14小时前
已完结
The structure-based virtual screening of non-benzofuran inhibitors againstM. tuberculosisPks13-TE for anti-tuberculosis phenotypic discovery
5天前
已完结
Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein–Ligand Complexes
29天前
已完结
Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein–Ligand Complexes
30天前
已完结
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
30天前
已完结
Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures
1个月前
已完结
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor
1个月前
已完结
Discovery of Thieno[2,3-d]pyrimidine-based KRAS G12D inhibitors as potential anticancer agents via combinatorial virtual screening
1个月前
已完结
没有进行任何应助
不需要了【积分已退回】
3小时前
文章内容不全
3小时前
文章内容不全
8小时前
感谢
14小时前
感谢
29天前
不符合求助备注哈
29天前
只有手稿吗,有没有出版的那种?
30天前
感谢
30天前
感谢
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论